Table 4

Comparison of values of traditional CV risk factors stratified by gender in patients with ERA (ESPOIR) and ESpA (DESIR)

	ESPOIR Patients with ERA				p* Value	DESIR Patients with ESpA				p* Value
	Men		Women			Men		Women
	N	Mean±SD	N	Mean±SD		N	Mean±SD	N	Mean±SD
Smoking†	149	36 (24.2)	475	95 (20)	0.329	174	67 (38.5)	219	69 (31.5)	0.179
SBP	159	132.3±16.9	518	127.4±15.3	0.001	295	123.5±13.6	332	116.3±13.4	<0.001
BMI	160	25.9±4.1	527	24.9±4.6	0.015	299	24.2±5.0	340	23.7±4.4	0.186
Glycaemia	151	97.7±32.6	490	91.8±26.9	0.026	293	88.0±11.2	326	83.8±12.2	<0.001
TChol	152	193.1±41.3	501	204.5±42.0	0.003	287	185.1±45.7	319	197.7±41.6	<0.001
HDL-cholesterol	80	47.8±15.3	273	60.7±17.9	<0.001	263	49.9±14.3	301	61.3±15.5	<0.001
LDL-cholesterol	80	114.3±33.8	272	119.2±37.5	0.299	260	113.6±36.9	299	117.0±38.4	0.288
TG	152	120.6±63.8	505	105.6±60.3	0.008	287	103.9±77.0	319	100.0±80.1	0.552
TChol/HDL	80	4.2±1.3	272	3.6±1.3	<0.001	262	3.9±1.2	300	3.4±0.9	<0.001
TG/HDL	80	2.8±1.9	273	2.1±2.2	0.011	261	2.3±2	300	1.8±1.5	0.001
PP	158	53.4±11.7	518	51.6±11.8	0.094	295	48.7±10.5	332	44.0±10.2	<0.001

All variables are in mg/dL, unless stated otherwise.
*Independent samples t test.
†N (%).
BMI, body mass index; CV, cardiovascular; DESIR, Devenir des Spondylarthropathies Indifférenciées Récentes; ERA, early rheumatoid arthritis; ESpA, early axial spondyloarthritis; ESPOIR, Etude et Suivi des Polyarthrites Indifférenciées Récentes; HDL, high-density lipoprotein; LDL, low-density lipoprotein; PP, pulse pressure; SBP, systolic blood pressure; TChol, total cholesterol; TG, triglycerides.